Publication | Open Access
Multi-Institutional Experience with FOLFIRINOX in Pancreatic Adenocarcinoma
112
Citations
9
References
2012
Year
Despite substantial rates of adverse events and use of dose modifications, FOLFIRINOX was found to be clinically effective in both metastatic and non-metastatic patients. Regimen toxicity did not detract from overall response and survival.
| Year | Citations | |
|---|---|---|
Page 1
Page 1